Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer

This publication has 35 references indexed in Scilit:

• Pathogenesis of osteoporosis
  The Lancet, 1993
• An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
  Bone, 1991
• Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia
  Bone, 1991
• HIP FRACTURES IN WOMEN WITH BREAST CANCER
  American Journal of Epidemiology, 1990
• Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
  British Journal of Cancer, 1990
• Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)
  British Journal of Cancer, 1988
• Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
  Bone, 1988
• The clinical course of bone metastases from breast cancer
  British Journal of Cancer, 1987
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982
• The assessment of phosphate reabsorption
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1969